PapersFlow Research Brief
Nuclear Receptors and Signaling
Research Guide
What is Nuclear Receptors and Signaling?
Nuclear receptors and signaling refers to the study of ligand-activated transcription factors, including Nurr1 (NR4A2), that regulate gene expression in response to signals, with a focus on protecting dopaminergic neurons from inflammation-induced death via pathways like Nurr1/CoREST in the context of Parkinson's disease and neurodegeneration.
This field encompasses 21,721 papers on nuclear receptors such as Nurr1 and their signaling mechanisms in transcriptional regulation, mitochondrial targeting, and apoptosis inhibition in dopaminergic neurons. Research highlights the Nurr1/CoREST pathway's role in preventing inflammation-induced neuronal death, relevant to Parkinson's disease. Growth data over the past 5 years is not available.
Topic Hierarchy
Research Sub-Topics
Nurr1 Transcriptional Regulation in Dopaminergic Neurons
This sub-topic investigates Nurr1 (NR4A2) as a master regulator of dopaminergic phenotype genes like TH and DAT. Researchers study promoter interactions, co-activators, and epigenetic controls in midbrain development.
Nurr1 Anti-Inflammatory Pathways in Neurodegeneration
Focuses on Nurr1 suppression of NF-κB and microglial activation protecting dopaminergic neurons from cytokine toxicity. Studies explore ligand screening and pathway crosstalk in PD models.
Nurr1 CoREST Complex in Neuronal Survival
Examines the Nurr1-CoREST repressor complex's role in blocking pro-apoptotic gene expression under stress. Research dissects complex assembly, nuclear localization, and modulation by inflammation.
Mitochondrial Targeting by Nuclear Receptors in PD
This area studies non-genomic actions of Nurr1 and related nuclear receptors on mitochondrial dynamics, fission-fusion, and bioenergetics in dopaminergic cells. Includes mitophagy regulation in toxin models.
NR4A Family in Apoptosis Regulation
Investigates pro- and anti-apoptotic functions of NR4A1-3 (Nurr1 homologs) via Bcl-2 translocation and mitochondrial outer membrane permeabilization. Comparative studies across neuronal and cancer contexts.
Why It Matters
Nuclear receptors and signaling research addresses neurodegeneration in Parkinson's disease by targeting pathways that protect dopaminergic neurons from inflammation. For instance, the Nurr1/CoREST pathway inhibits apoptosis and supports mitochondrial function in these neurons, offering potential therapeutic avenues. Studies like "Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism" (Kitada et al., 1998) link genetic defects in related pathways to early-onset Parkinson's, while "Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease" (Polymeropoulos et al., 1997) identifies mutations contributing to neuronal loss, underscoring the need for signaling interventions. "Epidemiology of Parkinson's disease" (de Lau and Breteler, 2006) reports a lifetime incidence of approximately 2 percent, emphasizing the scale of impact on public health.
Reading Guide
Where to Start
"Cloning of a novel receptor expressed in rat prostate and ovary" (Kuiper et al., 1996) is the starting paper, as it introduces a novel nuclear receptor with high homology to known family members, providing foundational understanding of receptor cloning and structure relevant to Nurr1-related signaling.
Key Papers Explained
Kuiper et al. (1996) in "Cloning of a novel receptor expressed in rat prostate and ovary" establishes nuclear receptor cloning techniques, building toward disease contexts. Kitada et al. (1998) in "Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism" links genetic mutations to Parkinson's, connecting to signaling defects in dopaminergic neurons. Polymeropoulos et al. (1997) in "Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease" identifies α-synuclein mutations, which intersect with nuclear receptor pathways like Nurr1 in neurodegeneration.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research continues to focus on the Nurr1/CoREST pathway's role in transcriptional regulation and mitochondrial protection in dopaminergic neurons, as per the core cluster description. No recent preprints or news from the last 12 months are available, indicating steady emphasis on established mechanisms in Parkinson's.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Al... | 1993 | Science | 9.3K | ✕ |
| 2 | α-Synuclein in Lewy bodies | 1997 | Nature | 8.2K | ✓ |
| 3 | Mutation in the α-Synuclein Gene Identified in Families with P... | 1997 | Science | 8.1K | ✕ |
| 4 | Akt Promotes Cell Survival by Phosphorylating and Inhibiting a... | 1999 | Cell | 6.5K | ✓ |
| 5 | Mutations in the parkin gene cause autosomal recessive juvenil... | 1998 | Nature | 5.2K | ✕ |
| 6 | Cloning of a novel receptor expressed in rat prostate and ovary. | 1996 | Proceedings of the Nat... | 4.8K | ✓ |
| 7 | α-Synuclein Locus Triplication Causes Parkinson's Disease | 2003 | Science | 4.3K | ✕ |
| 8 | Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques... | 1996 | Science | 4.2K | ✕ |
| 9 | Triple-Transgenic Model of Alzheimer's Disease with Plaques an... | 2003 | Neuron | 4.1K | ✓ |
| 10 | Epidemiology of Parkinson's disease | 2006 | The Lancet Neurology | 4.0K | ✕ |
Frequently Asked Questions
What role does Nurr1 play in nuclear receptor signaling?
Nurr1 (NR4A2) acts as a nuclear receptor that forms the Nurr1/CoREST complex to repress pro-apoptotic genes and protect dopaminergic neurons from inflammation. This pathway involves transcriptional regulation and mitochondrial targeting. It is central to research on Parkinson's disease.
How do nuclear receptors relate to Parkinson's disease?
Nuclear receptors like Nurr1 signaling pathways safeguard dopaminergic neurons against inflammation-induced death, a key feature of Parkinson's. Defects in related genes, such as parkin or α-synuclein, contribute to neurodegeneration. The field links these mechanisms to familial and sporadic forms of the disease.
What is the Nurr1/CoREST pathway?
The Nurr1/CoREST pathway is a nuclear receptor signaling mechanism that inhibits apoptosis in dopaminergic neurons during inflammation. It operates through transcriptional repression and mitochondrial protection. This pathway is implicated in preventing Parkinson's disease progression.
Which papers establish genetic links in Parkinson's relevant to nuclear signaling?
"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism" (Kitada et al., 1998) identifies parkin mutations causing early-onset disease tied to neuronal signaling defects. "Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease" (Polymeropoulos et al., 1997) locates a susceptibility gene on chromosome 4q. These inform nuclear receptor research contexts.
What is the scope of nuclear receptors and signaling research?
The field covers 21,721 papers on topics including Nurr1, dopaminergic neurons, inflammation, and neurodegeneration. It intersects with transcriptional regulation and apoptosis. Keywords include mitochondrial targeting and Parkinson's disease.
Open Research Questions
- ? How does the Nurr1/CoREST complex precisely target mitochondrial genes to prevent inflammation-induced dopaminergic neuron death?
- ? What upstream signals activate Nurr1 signaling in response to neuroinflammation in Parkinson's models?
- ? Can modulation of nuclear receptor pathways like Nurr1 restore function in parkin or α-synuclein mutant neurons?
- ? What are the downstream transcriptional targets of Nurr1 that inhibit apoptosis in dopaminergic neurons?
- ? How do interactions between nuclear receptors and α-synuclein aggregates influence Parkinson's progression?
Recent Trends
The field maintains 21,721 papers with no specified 5-year growth rate.
Core research persists on the Nurr1/CoREST pathway for dopaminergic neuron protection, as described in the topic cluster.
No recent preprints or news coverage from the last 6-12 months alters these directions.
Research Nuclear Receptors and Signaling with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Nuclear Receptors and Signaling with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers